These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
47. Enucleation vs Ophthalmic Artery Chemosurgery for Advanced Intraocular Retinoblastoma: A Retrospective Analysis. Yannuzzi NA; Francis JH; Marr BP; Belinsky I; Dunkel IJ; Gobin YP; Abramson DH JAMA Ophthalmol; 2015 Sep; 133(9):1062-6. PubMed ID: 26181236 [TBL] [Abstract][Full Text] [Related]
48. [Diagnosis and treatment of retinoblastoma: current strategies for effective tumour control and preservation of vision]. Temming P; Eggert A; Bornfeld N; Sauerwein W; Göricke S; Lohmann DR Klin Monbl Augenheilkd; 2013 Mar; 230(3):232-42. PubMed ID: 23508752 [TBL] [Abstract][Full Text] [Related]
49. Chemoreduction for retinoblastoma: analysis of tumor control and risks for recurrence in 457 tumors. Shields CL; Mashayekhi A; Cater J; Shelil A; Meadows AT; Shields JA Trans Am Ophthalmol Soc; 2004; 102():35-44; discussion 44-5. PubMed ID: 15747743 [TBL] [Abstract][Full Text] [Related]
50. Treatment of Retinoblastoma: The Role of External Beam Radiotherapy. Kim JY; Park Y Yonsei Med J; 2015 Nov; 56(6):1478-91. PubMed ID: 26446627 [TBL] [Abstract][Full Text] [Related]
51. Microscopic scleral invasion in retinoblastoma: clinicopathological features and outcome. Cuenca A; Giron F; Castro D; Fandiño A; Guitter M; de Dávila MT; Chantada G Arch Ophthalmol; 2009 Aug; 127(8):1006-10. PubMed ID: 19667337 [TBL] [Abstract][Full Text] [Related]
52. Management of retinoblastoma with proximal optic nerve enhancement on MRI at diagnosis. Armenian SH; Panigrahy A; Murphree AL; Jubran RF Pediatr Blood Cancer; 2008 Oct; 51(4):479-84. PubMed ID: 18478574 [TBL] [Abstract][Full Text] [Related]
54. Neoadjuvant/adjuvant treatment of high-risk retinoblastoma: a report from the German Retinoblastoma Referral Centre. Künkele A; Wilm J; Holdt M; Lohmann D; Bornfeld N; Eggert A; Temming P; Schulte JH Br J Ophthalmol; 2015 Jul; 99(7):949-53. PubMed ID: 25583279 [TBL] [Abstract][Full Text] [Related]
55. [Intraocular retinoblastoma: new therapeutic options]. Imhof SM; Moll AC; Schouten-van Meeteren AY Ned Tijdschr Geneeskd; 2001 Nov; 145(45):2165-70. PubMed ID: 11727614 [TBL] [Abstract][Full Text] [Related]
56. Salvage external beam radiotherapy after failed primary chemotherapy for bilateral retinoblastoma: rate of eye and vision preservation. Chan MP; Hungerford JL; Kingston JE; Plowman PN Br J Ophthalmol; 2009 Jul; 93(7):891-4. PubMed ID: 19329423 [TBL] [Abstract][Full Text] [Related]
57. Intravenous and intra-arterial chemotherapy for retinoblastoma: what have we learned? Shields CL; Kaliki S; Rojanaporn D; Al-Dahmash S; Bianciotto CG; Shields JA Curr Opin Ophthalmol; 2012 May; 23(3):202-9. PubMed ID: 22450222 [TBL] [Abstract][Full Text] [Related]
58. Transpupillary thermotherapy as initial treatment for small intraocular retinoblastoma: technique and predictors of success. Abramson DH; Schefler AC Ophthalmology; 2004 May; 111(5):984-91. PubMed ID: 15121378 [TBL] [Abstract][Full Text] [Related]
59. Development of new retinoblastomas after 6 cycles of chemoreduction for retinoblastoma in 162 eyes of 106 consecutive patients. Shields CL; Shelil A; Cater J; Meadows AT; Shields JA Arch Ophthalmol; 2003 Nov; 121(11):1571-6. PubMed ID: 14609913 [TBL] [Abstract][Full Text] [Related]
60. Targeted retinoblastoma management: when to use intravenous, intra-arterial, periocular, and intravitreal chemotherapy. Shields CL; Lally SE; Leahey AM; Jabbour PM; Caywood EH; Schwendeman R; Shields JA Curr Opin Ophthalmol; 2014 Sep; 25(5):374-85. PubMed ID: 25014750 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]